Top Midday Decliners

MT Newswires Live06-30

Evommune's (EVMN) top-line results from a phase 2b trial of EVO756 to treat adults with moderate-to-severe chronic spontaneous urticaria failed to meet the primary endpoint at any dosage, according to a statement released Monday.

Shares sank 39% as intraday trading volume surged to over 5.9 million from a daily average of about 415,000.

Solidion Technology (STI) said Monday it plans to opportunistically acquire shares of SpaceX (SPCX) as a long-term strategic treasury asset, using a modest portion of its cash reserves.

Shares of Solidion slumped 20%, with intraday trading volume climbing to about 2.4 million from a daily average of roughly 2.8 million.

Martin Marietta Materials (MLM) agreed to combine with limestone supplier Lhoist North America in a $13.5 billion deal.

Shares dropped 6.6% as intraday trading volume rose to more than 759,300 from a daily average of about 509,000.

Price: 15.35, Change: -9.83, Percent Change: -39.04

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment